KRONOS WORLDWIDE INC (KRO) Stock Fundamental Analysis

NYSE:KRO • US50105F1057

5.81 USD
+0.16 (+2.83%)
At close: Feb 27, 2026
5.81 USD
0 (0%)
After Hours: 2/27/2026, 8:14:58 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

KRO gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 83 industry peers in the Chemicals industry. The financial health of KRO is average, but there are quite some concerns on its profitability. KRO is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • KRO had negative earnings in the past year.
  • In the past year KRO has reported a negative cash flow from operations.
  • Of the past 5 years KRO 4 years were profitable.
  • Each year in the past 5 years KRO had a positive operating cash flow.
KRO Yearly Net Income VS EBIT VS OCF VS FCFKRO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

1.2 Ratios

  • KRO has a worse Return On Assets (-2.16%) than 60.24% of its industry peers.
  • Looking at the Return On Equity, with a value of -5.13%, KRO is doing worse than 60.24% of the companies in the same industry.
  • The Return On Invested Capital of KRO (2.68%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -2.16%
ROE -5.13%
ROIC 2.68%
ROA(3y)2.41%
ROA(5y)3.2%
ROE(3y)5.13%
ROE(5y)7.28%
ROIC(3y)N/A
ROIC(5y)N/A
KRO Yearly ROA, ROE, ROICKRO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

  • KRO's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 2.97%, KRO is doing worse than 63.86% of the companies in the same industry.
  • In the last couple of years the Operating Margin of KRO has declined.
  • KRO has a Gross Margin of 16.25%. This is in the lower half of the industry: KRO underperforms 72.29% of its industry peers.
  • In the last couple of years the Gross Margin of KRO has declined.
Industry RankSector Rank
OM 2.97%
PM (TTM) N/A
GM 16.25%
OM growth 3Y-12.41%
OM growth 5Y-5.03%
PM growth 3Y-7.77%
PM growth 5Y-1.91%
GM growth 3Y-6.11%
GM growth 5Y-3.12%
KRO Yearly Profit, Operating, Gross MarginsKRO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so KRO is destroying value.
  • KRO has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, KRO has less shares outstanding
  • Compared to 1 year ago, KRO has a worse debt to assets ratio.
KRO Yearly Shares OutstandingKRO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
KRO Yearly Total Debt VS Total AssetsKRO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • KRO has an Altman-Z score of 1.74. This is a bad value and indicates that KRO is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.74, KRO is in line with its industry, outperforming 45.78% of the companies in the same industry.
  • A Debt/Equity ratio of 0.78 indicates that KRO is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.78, KRO is in line with its industry, outperforming 44.58% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Altman-Z 1.74
ROIC/WACC0.23
WACC11.75%
KRO Yearly LT Debt VS Equity VS FCFKRO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 3.83 indicates that KRO has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 3.83, KRO belongs to the best of the industry, outperforming 90.36% of the companies in the same industry.
  • KRO has a Quick Ratio of 1.47. This is a normal value and indicates that KRO is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of KRO (1.47) is better than 62.65% of its industry peers.
Industry RankSector Rank
Current Ratio 3.83
Quick Ratio 1.47
KRO Yearly Current Assets VS Current LiabilitesKRO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • KRO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -244.00%.
  • The earnings per share for KRO have been decreasing by -24.83% on average. This is quite bad
  • The Revenue has been growing slightly by 0.01% in the past year.
  • The Revenue has been growing slightly by 1.74% on average over the past years.
EPS 1Y (TTM)-244%
EPS 3Y-43.16%
EPS 5Y-24.83%
EPS Q2Q%-633.33%
Revenue 1Y (TTM)0.01%
Revenue growth 3Y-0.91%
Revenue growth 5Y1.74%
Sales Q2Q%-5.74%

3.2 Future

  • Based on estimates for the next years, KRO will show a very strong growth in Earnings Per Share. The EPS will grow by 39.61% on average per year.
  • Based on estimates for the next years, KRO will show a small growth in Revenue. The Revenue will grow by 0.80% on average per year.
EPS Next Y-335.67%
EPS Next 2Y-39.61%
EPS Next 3Y39.61%
EPS Next 5YN/A
Revenue Next Year-12.6%
Revenue Next 2Y-4.19%
Revenue Next 3Y0.8%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
KRO Yearly Revenue VS EstimatesKRO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
KRO Yearly EPS VS EstimatesKRO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for KRO. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 88.50, the valuation of KRO can be described as expensive.
  • KRO's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. KRO is more expensive than 67.47% of the companies in the same industry.
  • KRO is valuated expensively when we compare the Price/Forward Earnings ratio to 28.05, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 88.5
KRO Price Earnings VS Forward Price EarningsKRO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

  • KRO's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.41
KRO Per share dataKRO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • A more expensive valuation may be justified as KRO's earnings are expected to grow with 39.61% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-39.61%
EPS Next 3Y39.61%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 3.54%, KRO has a reasonable but not impressive dividend return.
  • KRO's Dividend Yield is rather good when compared to the industry average which is at 2.19. KRO pays more dividend than 81.93% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, KRO pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.54%

5.2 History

  • The dividend of KRO decreases each year by -7.80%.
  • KRO has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-7.8%
Div Incr Years0
Div Non Decr Years0
KRO Yearly Dividends per shareKRO Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

  • The earnings of KRO are negative and hence is the payout ratio. KRO will probably not be able to sustain this dividend level.
DP-55.69%
EPS Next 2Y-39.61%
EPS Next 3Y39.61%
KRO Yearly Income VS Free CF VS DividendKRO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

More info and screens

Find the best dividend stocksShow peers with best dividend

KRONOS WORLDWIDE INC

NYSE:KRO (2/27/2026, 8:14:58 PM)

After market: 5.81 0 (0%)

5.81

+0.16 (+2.83%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-06
Earnings (Next)03-09
Inst Owners16.83%
Inst Owner Change-5.69%
Ins Owners0.17%
Ins Owner Change0%
Market Cap668.44M
Revenue(TTM)1.86B
Net Income(TTM)-41.30M
Analysts46.67
Price Target5.61 (-3.44%)
Short Float %7.99%
Short Ratio4.78
Dividend
Industry RankSector Rank
Dividend Yield 3.54%
Yearly Dividend0.48
Dividend Growth(5Y)-7.8%
DP-55.69%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-293.36%
Min EPS beat(2)-428.05%
Max EPS beat(2)-158.67%
EPS beat(4)0
Avg EPS beat(4)-195.61%
Min EPS beat(4)-428.05%
Max EPS beat(4)-6.81%
EPS beat(8)3
Avg EPS beat(8)-2%
EPS beat(12)3
Avg EPS beat(12)-62.91%
EPS beat(16)6
Avg EPS beat(16)-38.64%
Revenue beat(2)0
Avg Revenue beat(2)-3.64%
Min Revenue beat(2)-4.26%
Max Revenue beat(2)-3.02%
Revenue beat(4)0
Avg Revenue beat(4)-6.45%
Min Revenue beat(4)-15.25%
Max Revenue beat(4)-3.02%
Revenue beat(8)2
Avg Revenue beat(8)-5.34%
Revenue beat(12)4
Avg Revenue beat(12)-2.96%
Revenue beat(16)7
Avg Revenue beat(16)-1.72%
PT rev (1m)0%
PT rev (3m)-18.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-390%
EPS NY rev (1m)0%
EPS NY rev (3m)-1300%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.17%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.4%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 88.5
P/S 0.36
P/FCF N/A
P/OCF N/A
P/B 0.83
P/tB 0.83
EV/EBITDA 11.41
EPS(TTM)-0.36
EYN/A
EPS(NY)0.07
Fwd EY1.13%
FCF(TTM)-0.74
FCFYN/A
OCF(TTM)-0.35
OCFYN/A
SpS16.2
BVpS6.99
TBVpS6.97
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.16%
ROE -5.13%
ROCE 3.39%
ROIC 2.68%
ROICexc 2.73%
ROICexgc 2.73%
OM 2.97%
PM (TTM) N/A
GM 16.25%
FCFM N/A
ROA(3y)2.41%
ROA(5y)3.2%
ROE(3y)5.13%
ROE(5y)7.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-13.41%
ROICexgc growth 5Y-3.71%
ROICexc growth 3Y-13.47%
ROICexc growth 5Y-3.75%
OM growth 3Y-12.41%
OM growth 5Y-5.03%
PM growth 3Y-7.77%
PM growth 5Y-1.91%
GM growth 3Y-6.11%
GM growth 5Y-3.12%
F-Score3
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Debt/EBITDA 5.64
Cap/Depr 80.79%
Cap/Sales 2.41%
Interest Coverage 1.08
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.83
Quick Ratio 1.47
Altman-Z 1.74
F-Score3
WACC11.75%
ROIC/WACC0.23
Cap/Depr(3y)89.54%
Cap/Depr(5y)98.19%
Cap/Sales(3y)2.56%
Cap/Sales(5y)2.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-244%
EPS 3Y-43.16%
EPS 5Y-24.83%
EPS Q2Q%-633.33%
EPS Next Y-335.67%
EPS Next 2Y-39.61%
EPS Next 3Y39.61%
EPS Next 5YN/A
Revenue 1Y (TTM)0.01%
Revenue growth 3Y-0.91%
Revenue growth 5Y1.74%
Sales Q2Q%-5.74%
Revenue Next Year-12.6%
Revenue Next 2Y-4.19%
Revenue Next 3Y0.8%
Revenue Next 5YN/A
EBIT growth 1Y-36.36%
EBIT growth 3Y-13.2%
EBIT growth 5Y-3.37%
EBIT Next Year-56.35%
EBIT Next 3Y9.68%
EBIT Next 5YN/A
FCF growth 1Y12.24%
FCF growth 3Y-33.75%
FCF growth 5Y-16.38%
OCF growth 1Y-11.02%
OCF growth 3Y-29.45%
OCF growth 5Y-14.67%

KRONOS WORLDWIDE INC / KRO FAQ

What is the ChartMill fundamental rating of KRONOS WORLDWIDE INC (KRO) stock?

ChartMill assigns a fundamental rating of 3 / 10 to KRO.


Can you provide the valuation status for KRONOS WORLDWIDE INC?

ChartMill assigns a valuation rating of 1 / 10 to KRONOS WORLDWIDE INC (KRO). This can be considered as Overvalued.


How profitable is KRONOS WORLDWIDE INC (KRO) stock?

KRONOS WORLDWIDE INC (KRO) has a profitability rating of 2 / 10.


How financially healthy is KRONOS WORLDWIDE INC?

The financial health rating of KRONOS WORLDWIDE INC (KRO) is 4 / 10.


What is the earnings growth outlook for KRONOS WORLDWIDE INC?

The Earnings per Share (EPS) of KRONOS WORLDWIDE INC (KRO) is expected to decline by -335.67% in the next year.